Suppr超能文献

术前硬膜外类固醇注射不会增加后路颈椎手术后的感染风险。

Preoperative Epidural Steroid Injection Does Not Increase Infection Risk Following Posterior Cervical Surgery.

机构信息

Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

出版信息

Spine (Phila Pa 1976). 2023 Dec 1;48(23):1658-1662. doi: 10.1097/BRS.0000000000004647. Epub 2023 Mar 27.

Abstract

STUDY DESIGN

Retrospective cohort study.

OBJECTIVE

The purpose of this study was to characterize the infection risk of preoperative epidural steroid injection (ESI) in patients undergoing posterior cervical surgery.

SUMMARY OF BACKGROUND DATA

ESI is a helpful tool for alleviating pain and is often used as a diagnostic tool before cervical surgery. However, a recent small-scale study found that ESI before cervical fusion was associated with an increased risk of postoperative infection.

MATERIALS AND METHODS

Patients from 2010 to 2020 with cervical myelopathy, spondylosis, and radiculopathy who underwent posterior cervical procedure including laminectomy, laminoforaminotomy, fusion, or laminoplasty were queried from the PearlDiver database. Patients who underwent revision or fusion above C2 or who had a diagnosis of neoplasm, trauma, or preexisting infection were excluded. Patients were divided on whether they received an ESI within 30 days before the procedure and subsequently matched by age, sex, and preoperative comorbidities. The χ 2 analysis was used to calculate the risk of postoperative infection within 90 days. Logistic regression controlling for age, sex, Elixhauser Comorbidity Index, and operated levels was conducted within the unmatched population to assess infection risk for injected patients across procedure subgroups.

RESULTS

Overall, 299,417 patients were identified with 3897 having received a preoperative ESI and 295,520 who did not. Matching resulted in 975 in the injected group and 1929 in the control group. There was no significant difference in postoperative infection rate in those who received an ESI within 30 days preoperatively and those who did not (3.28% vs. 3.78%, odds ratio=0.86, 95% CI: 0.57-1.32, P =0.494). Logistic regression accounting for age, sex, Elixhauser Comorbidity Index, and levels operated demonstrated that injection did not significantly increase infection risk in any of the procedure subgroups.

CONCLUSIONS

The present study found no association between preoperative ESI within 30 days before surgery and postoperative infection in patients undergoing posterior cervical surgery.

摘要

研究设计

回顾性队列研究。

目的

本研究旨在描述接受颈椎后路手术的患者行术前硬膜外类固醇注射(ESI)的感染风险。

背景资料概要

ESI 是一种缓解疼痛的有效工具,常用于颈椎手术前的诊断。然而,最近一项小规模研究发现,颈椎融合术前 ESI 与术后感染风险增加有关。

材料和方法

从 PearlDiver 数据库中查询了 2010 年至 2020 年患有颈椎病、颈椎病和神经根病并接受后路颈椎手术(包括椎板切除术、椎板切开术、融合术或椎板成形术)的患者。排除了接受颈椎以上 C2 翻修或融合术或患有肿瘤、创伤或先前感染的患者。根据是否在手术前 30 天内接受 ESI 治疗将患者分为两组,并按年龄、性别和术前合并症进行匹配。χ 2 分析用于计算术后 90 天内感染的风险。在未匹配人群中进行控制年龄、性别、Elixhauser 合并症指数和手术节段的 logistic 回归,以评估不同手术亚组中接受注射治疗患者的感染风险。

结果

总体而言,共确定了 299417 名患者,其中 3897 名患者接受了术前 ESI,295520 名患者未接受 ESI。匹配后,注射组有 975 例,对照组有 1929 例。在术前 30 天内接受 ESI 和未接受 ESI 的患者中,术后感染率无显著差异(3.28%对 3.78%,比值比=0.86,95%CI:0.57-1.32,P=0.494)。考虑年龄、性别、Elixhauser 合并症指数和手术节段的 logistic 回归表明,在任何手术亚组中,注射均未显著增加感染风险。

结论

本研究未发现颈椎后路手术后 30 天内行术前 ESI 与术后感染之间存在关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验